← Leaderboards
Jasmeer P Chhatwal
Massachusetts General Hospital
$14,773,867
Attributed
$22,472,168
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,472,168 · 9
By mechanism
R01$15,679,403 · 4
RF1$4,352,115 · 1
P01$1,385,740 · 2
K23$930,960 · 1
F30$123,950 · 1
Top collaborators
- Lei Liu2 shared
- Michael S Wolfe2 shared
- Adam P Bress1 shared
- Jeremy Joseph Pruzin1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Herminia D Rosas$18,624,312
- Aaron P Schultz$3,030,563
- Kathryn Johnson Gray$2,218,883
- Deborah L. Blacker$5,341,305
- Steven E Arnold$15,876,281
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBiological MarkersAmyloidPositron-Emission TomographyCognitiveParticipantMagnetic Resonance ImagingTau ProteinsPathologyPathologicImpaired CognitionTau AggregationCognitive PerformanceCognitionPatternS Disease PathologyAlzheimerâS Disease BiomarkerImageImaging BiomarkerFundingî²-Amyloid BurdenNerve DegenerationDementia
Grant awards (27)
Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the racially and ethnically diverse SPRINT trial$5,789,766
R01 · FY2025 · AG
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers$1,405,570
R01 · FY2025 · AG · contact PI
Plasma tau and neurodegenerative markers as predictors of rate of AD progression$831,219
R01 · FY2025 · AG · contact PI
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)$257,873
P01 · FY2025 · AG · contact PI
Plasma tau and neurodegenerative markers as predictors of rate of AD progression$848,183
R01 · FY2024 · AG · contact PI
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease$843,700
R01 · FY2024 · AG · contact PI
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)$265,568
P01 · FY2024 · AG · contact PI
Plasma tau and neurodegenerative markers as predictors of rate of AD progression$848,183
R01 · FY2023 · AG · contact PI
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease$847,416
R01 · FY2023 · AG · contact PI
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)$265,568
P01 · FY2023 · AG · contact PI
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers$4,352,115
RF1 · FY2022 · AG · contact PI
Plasma tau and neurodegenerative markers as predictors of rate of AD progression$848,183
R01 · FY2022 · AG · contact PI
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease$836,646
R01 · FY2022 · AG · contact PI
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)$277,403
P01 · FY2022 · AG · contact PI
Plasma tau and neurodegenerative markers as predictors of rate of AD progression$865,183
R01 · FY2021 · AG · contact PI
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease$847,144
R01 · FY2021 · AG · contact PI
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)$319,328
P01 · FY2020 · AG · contact PI
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease$868,210
R01 · FY2019 · AG · contact PI
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD$200,880
K23 · FY2019 · AG · contact PI
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD$200,880
K23 · FY2018 · AG · contact PI
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD$200,880
K23 · FY2017 · AG · contact PI
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD$164,160
K23 · FY2016 · AG · contact PI
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD$164,160
K23 · FY2015 · AG · contact PI
Inhibitory interneurons in fear conditioning and extinction$36,005
F30 · FY2007 · MH · contact PI
Inhibitory interneurons in fear cond. and extinction$37,123
F30 · FY2006 · MH · contact PI
Inhibitory interneurons in fear cond. and extinction$25,447
F30 · FY2005 · MH
Inhibitory interneurons: Fear conditioning/extinction$25,375
F30 · FY2004 · MH